glwl-01
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02377362)
Timeline
Indications
Mechanism of action
- Ghrelin O-acyltransferaseINHIBITOR
MBOAT4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glwl-01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03896516 | Phase 1/Phase 2 (Phase 2) | Jul 5, 2019 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| NCT03641417 | N/A | Oct 1, 2018 | University of London |
| NCT03274856 | Phase 2 | Feb 20, 2018 | GLWL Research Inc. |
| NCT02377362 | Phase 1 | Mar 1, 2015 | GLWL Research Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GLWL Research Inc. | For profit | 2 | 2 | 2 | 2015 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Government | 1 | 1 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1